Populated Printable COP 2009 Cote D'ivoire Generated 9/28/2009 12:01:26 AM
Total Page:16
File Type:pdf, Size:1020Kb
Populated Printable COP 2009 Cote d'Ivoire Generated 9/28/2009 12:01:26 AM ***pages: 518*** Cote d'Ivoire Page 1 Table 1: Overview Executive Summary File Name Content Type Date Uploaded Description Uploaded By COP09 Exec Summary- application/msword 11/14/2008 CI Executive Summary OTossou bh-bbs-bh-13nov08.doc Country Program Strategic Overview Will you be submitting changes to your country's 5-Year Strategy this year? If so, please briefly describe the changes you will be submitting. Yes X No Description: Ambassador Letter File Name Content Type Date Uploaded Description Uploaded By Ambassador letter-CI- application/pdf 11/14/2008 CI Ambassador Letter OTossou 14nov08.pdf Country Contacts Contact Type First Name Last Name Title Email PEPFAR Coordinator Brian Howard COP Manager (not Country [email protected] Coordinator) PEPFAR Coordinator James Allman Interim Coordinator [email protected] DOD In-Country Contact Patrick Doyle Defense Attaché [email protected] HHS/CDC In-Country Contact Bruce Struminger CDC Chief of Party [email protected] USAID In-Country Contact Toussaint Sibailly USAID Focal Point [email protected] U.S. Embassy In-Country Cynthia Akuetteh DCM [email protected] Contact Global Fund What is the planned funding for Global Fund Technical Assistance in FY 2009? $350000 Does the USG assist GFATM proposal writing? Yes Does the USG participate on the CCM? Yes Generated 9/28/2009 12:01:26 AM ***pages: 518*** Cote d'Ivoire Page 2 Table 2: Prevention, Care, and Treatment Targets 2.1 Targets for Reporting Period Ending September 30, 2009 National 2-7-10 USG USG Upstream USG Total Target Downstream (Indirect) Target End FY2009 (Direct) Target End FY2009 End FY2009 Prevention End of Plan Goal 265,655 1.2 - Number of pregnant women who received HIV counseling and 0 240,000 60,000 300,000 testing for PMTCT and received their test results 1.3 - Number of HIV-infected pregnant women who received 0 9,600 2,400 12,000 antiretroviral prophylaxis for PMTCT in a PMTCT setting National 2-7-10 USG USG Upstream USG Total Target Downstream (Indirect) Target End FY2009 (Direct) Target End FY2009 End FY2009 Care (1) 270,000 20,000 290,000 End of Plan Goal 385,000 6.2 - Total number of individuals provided with HIV-related palliative 0 190,000 15,000 205,000 care (including TB/HIV) ***7.2 - Number of HIV-infected clients attending HIV care/treatment 0 8,000 0 8,000 services that are receiving treatment for TB disease (a subset of indicator 6.2) 8.1 - Number of OVC served by OVC programs 0 80,000 5,000 85,000 9.2 - Number of individuals who received counseling and testing for 0 400,000 35,000 435,000 HIV and received their test results (including TB) National 2-7-10 USG USG Upstream USG Total Target Downstream (Indirect) Target End FY2009 (Direct) Target End FY2009 End FY2009 Treatment 60,000 12,000 72,000 End of Plan Goal 77,000 11.4 - Number of individuals receiving antiretroviral therapy at the 0 60,000 12,000 72,000 end of the reporting period National 2-7-10 USG USG Upstream USG Total Target Downstream (Indirect) Target End FY2009 (Direct) Target End FY2009 End FY2009 Human Resources for Health 567 0 567 End of Plan Goal 0 Number of new health care workers who graduated from a pre- 0 567 0 567 service training institution within the reporting period. Generated 9/28/2009 12:01:26 AM ***pages: 518*** Cote d'Ivoire Page 3 2.2 Targets for Reporting Period Ending September 30, 2010 USG USG Upstream USG Total Target Downstream (Indirect) Target End FY2010 (Direct) Target End FY2010 End FY2010 Prevention End of Plan Goal 1.2 - Number of pregnant women who received HIV counseling and 380,000 95,000 475,000 testing for PMTCT and received their test results 1.3 - Number of HIV-infected pregnant women who received 15,200 3,800 19,000 antiretroviral prophylaxis for PMTCT in a PMTCT setting USG USG Upstream USG Total Target Downstream (Indirect) Target End FY2010 (Direct) Target End FY2010 End FY2010 Care (1) 315,000 25,000 340,000 End of Plan Goal 6.2 - Total number of individuals provided with HIV-related palliative 230,000 20,000 250,000 care (including TB/HIV) ***7.2 - Number of HIV-infected clients attending HIV care/treatment 10,000 0 10,000 services that are receiving treatment for TB disease (a subset of indicator 6.2) 8.1 - Number of OVC served by OVC programs 85,000 5,000 90,000 9.2 - Number of individuals who received counseling and testing for 480,000 50,000 530,000 HIV and received their test results (including TB) USG USG Upstream USG Total Target Downstream (Indirect) Target End FY2010 (Direct) Target End FY2010 End FY2010 Treatment 65,000 15,000 80,000 End of Plan Goal 11.4 - Number of individuals receiving antiretroviral therapy at the 65,000 15,000 80,000 end of the reporting period USG USG Upstream USG Total Target Downstream (Indirect) Target End FY2010 (Direct) Target End FY2010 End FY2010 Human Resources for Health 1,000 0 1,000 End of Plan Goal Number of new health care workers who graduated from a pre- 1,000 0 1,000 service training institution within the reporting period. Generated 9/28/2009 12:01:26 AM ***pages: 518*** Cote d'Ivoire Page 4 (1) Total Care represents number of OVC served by an OVC program during the reporting period and the number of individuals provided with facility-based, community-based and/or home-based HIV-related palliative care, including those HIV-infected individuals who received clinical prophylaxis and/or treatment for tuberculosis(TB). Generated 9/28/2009 12:01:26 AM ***pages: 518*** Cote d'Ivoire Page 5 Table 3.1: Funding Mechanisms and Source Mechanism Name: Country top-up ABY Hope Worldwide #GPO-A-11-05-00007-00 Mechanism Type: HQ - Headquarters procured, country funded Mechanism ID: 5319.09 System ID: 9662 Planned Funding($): Procurement/Assistance Instrument: Cooperative Agreement Agency: U.S. Agency for International Development Funding Source: GHCS (State) Prime Partner: To Be Determined New Partner: No Mechanism Name: Country top-up OVC Hope Worldwide #GPO-A-11-05-00014-00 Mechanism Type: HQ - Headquarters procured, country funded Mechanism ID: 5318.09 System ID: 9663 Planned Funding($): Procurement/Assistance Instrument: Cooperative Agreement Agency: U.S. Agency for International Development Funding Source: GHCS (State) Prime Partner: To Be Determined New Partner: No Mechanism Name: PHE 08 PMTCT Coll TBD Mechanism Type: HQ - Headquarters procured, country funded Mechanism ID: 11921.09 System ID: 11921 Planned Funding($): Procurement/Assistance Instrument: Contract Agency: HHS/Centers for Disease Control & Prevention Funding Source: GHCS (State) Prime Partner: To Be Determined New Partner: No Mechanism Name: TBD (INFAS) Mechanism Type: HQ - Headquarters procured, country funded Mechanism ID: 12161.09 System ID: 12161 Planned Funding($): Procurement/Assistance Instrument: USG Core Agency: HHS/Centers for Disease Control & Prevention Funding Source: GHCS (State) Prime Partner: To Be Determined New Partner: No Generated 9/28/2009 12:01:26 AM ***pages: 518*** Cote d'Ivoire Page 6 Table 3.1: Funding Mechanisms and Source Mechanism Name: TBD (LNSP) Mechanism Type: HQ - Headquarters procured, country funded Mechanism ID: 12162.09 System ID: 12162 Planned Funding($): Procurement/Assistance Instrument: USG Core Agency: HHS/Centers for Disease Control & Prevention Funding Source: GHCS (State) Prime Partner: To Be Determined New Partner: No Mechanism Name: TBD Audits Mechanism Type: HQ - Headquarters procured, country funded Mechanism ID: 12171.09 System ID: 12171 Planned Funding($): $100,000 Procurement/Assistance Instrument: Contract Agency: HHS/Centers for Disease Control & Prevention Funding Source: GHCS (State) Prime Partner: To Be Determined New Partner: No Mechanism Name: TBD Drugs Mechanism Type: HQ - Headquarters procured, country funded Mechanism ID: 12166.09 System ID: 12166 Planned Funding($): Procurement/Assistance Instrument: Contract Agency: U.S. Agency for International Development Funding Source: GHCS (State) Prime Partner: To Be Determined New Partner: No Mechanism Name: TBD Institut Pasteur Mechanism Type: HQ - Headquarters procured, country funded Mechanism ID: 10822.09 System ID: 10822 Planned Funding($): Procurement/Assistance Instrument: Cooperative Agreement Agency: HHS/Centers for Disease Control & Prevention Funding Source: GHCS (State) Prime Partner: To Be Determined New Partner: Yes Generated 9/28/2009 12:01:26 AM ***pages: 518*** Cote d'Ivoire Page 7 Table 3.1: Funding Mechanisms and Source Mechanism Name: TBD MS Mechanism Type: HQ - Headquarters procured, country funded Mechanism ID: 12167.09 System ID: 12167 Planned Funding($): Procurement/Assistance Instrument: USG Core Agency: HHS/Centers for Disease Control & Prevention Funding Source: GHCS (State) Prime Partner: To Be Determined New Partner: No Mechanism Name: TBD New CDC TA Mech Rural Mechanism Type: HQ - Headquarters procured, country funded Mechanism ID: 12170.09 System ID: 12170 Planned Funding($): Procurement/Assistance Instrument: Cooperative Agreement Agency: HHS/Centers for Disease Control & Prevention Funding Source: GHCS (State) Prime Partner: To Be Determined New Partner: Yes Mechanism Name: TBD New Treatment Partner Mechanism Type: HQ - Headquarters procured, country funded Mechanism ID: 11044.09 System ID: 11044 Planned Funding($): Procurement/Assistance Instrument: Cooperative Agreement Agency: HHS/Centers for Disease Control & Prevention Funding Source: GHCS (State) Prime Partner: To Be Determined New Partner: Yes Mechanism Name: TBD Partnership Framework Consult Process Mechanism